Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.58 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.58 |
| ▸ | CA12 | O43570 | 1/20 | 0.58 |
| ▸ | CA1 | P00915 | 1/20 | 0.58 |
| ▸ | CA2 | P00918 | 1/20 | 0.58 |
| ▸ | CA7 | P43166 | 1/20 | 0.58 |
| ▸ | CA9 | Q16790 | 1/20 | 0.58 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.58 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.56 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.56 |
| ▸ | LMNA | P02545 | 2/20 | 0.56 |
| ▸ | TP53 | P04637 | 1/20 | 0.56 |
| ▸ | TSHR | P16473 | 1/20 | 0.56 |
| ▸ | HPGD | P15428 | 2/20 | 0.56 |
| ▸ | MAPT | P10636 | 1/20 | 0.56 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.54 |
| ▸ | RELA | Q04206 | 1/20 | 0.54 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.52 |
| ▸ | CYP1A1 | P04798 | 3/20 | 0.52 |
| ▸ | CYP1B1 | Q16678 | 3/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4881152 | 0.78 | RELA (0.81) | ALDH1A1KDM4ECYP3A4LMNATP53 | |
| SCHEMBL699458 | 0.78 | RELA (0.81) | ALDH1A1KDM4ECYP3A4LMNATP53 | |
| SCHEMBL27883 | 0.78 | CA12 (0.65) | ALDH1A1CYP2A6CA12CA1CA2 | |
| SCHEMBL14950253 | 0.78 | RELA (0.81) | ALDH1A1KDM4ECYP3A4LMNATP53 | |
| SCHEMBL699457 | 0.78 | RELA (0.81) | ALDH1A1KDM4ECYP3A4LMNATP53 | |
| SCHEMBL631998 | 0.78 | RELA (0.81) | ALDH1A1KDM4ECYP3A4LMNATP53 | |
| SCHEMBL13790336 | 0.78 | RELA (0.81) | ALDH1A1KDM4ECYP3A4LMNATP53 | |
| 1,4-Dimethoxybenzene SCHEMBL8489 | 0.76 | CA1 (1.00) | ALDH1A1CYP2A6CA12CA1CA2 | |
| 1,4-Dimethoxybenzene SCHEMBL21802643 | 0.76 | CA1 (1.00) | ALDH1A1CYP2A6CA12CA1CA2 | |
| SCHEMBL97603 | 0.76 | KDM4E (0.65) | ALDH1A1CYP2A6CA12CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 142 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-101754956-B | Substituted indazole derivatives active as kinase inhibitors | NERVIANO MEDICAL SCIENCES SRL | 2014-04-23 | — | — | CN | claimed |
| CN-101663287-B | Semi-synthetic process for the preparation of taxane derivatives | CHATHAM BIOTEC LTD | 2013-06-19 | — | — | CN | claimed |
| US-8299279-B2 | Semi-synthetic process for the preparation of taxane derivatives | CHATHAM BIOTEC LTD. (CA) | 2012-10-30 | — | — | US | claimed |
| CN-101754956-A | Substituted indazole derivatives active as kinase inhibitors | NERVIANO MEDICAL SCIENCES SRL | 2010-06-23 | — | — | CN | claimed |
| CN-101663287-A | Semi-synthetic process for the preparation of taxane derivatives | CHATHAM BIOTEC LTD | 2010-03-03 | — | — | CN | claimed |
| US-20100029957-A1 | Semi-Synthetic Process for the Preparation of Taxane Derivatives | CHATHAM BRUNSWICK BIOTEC LTD (CA) | 2010-02-04 | — | — | US | claimed |
| EP-2114908-A1 | SEMI-SYNTHETIC PROCESS FOR THE PREPARATION OF TAXANE DERIVATIVES | Chatham Biotec Ltd (CA) | 2009-11-11 | — | — | EP | claimed |
| WO-2008090368-A1 | SEMI-SYNTHETIC PROCESS FOR THE PREPARATION OF TAXANE DERIVATIVES | CHATHAM BIOTEC LTD (CA) | 2008-07-31 | — | — | WO | claimed |
| US-6605590-B1 | Essential amino acids, nutrients, oligopeptides | NOVUS INTERNATIONAL, INC. | 2003-08-12 | — | — | US | claimed |
| EP-0292808-B1 | Substituted vinyl cephalosporins, process for their preparation and their use as medicines | BAYER AG (DE) | 1994-03-02 | — | — | EP | claimed |
| US-4849531-A | Process for the preparation of 2,3-epoxyamides | BAYER AKTIENGESELLSCHAFT (DE) | 1989-07-18 | — | — | US | claimed |
| EP-0292808-A2 | Substituted vinyl cephalosporins, process for their preparation and their use as medicines | BAYER AG (DE) | 1988-11-30 | — | — | EP | claimed |
| EP-0244717-A2 | Process for the preparation of 2,3-epoxyamides | BAYER AG (DE) | 1987-11-11 | — | — | EP | claimed |
| CN-118234628-A | Thermosensitive recording medium | 日本制纸株式会社 | 2024-06-21 | — | — | CN | disclosed |
| US-20240190156-A1 | THERMOSENSITIVE RECORDING MEDIUM | NIPPON PAPER INDUSTRIES CO., LTD. (JP) | 2024-06-13 | — | — | US | disclosed |
| US-11912052-B2 | Thermosensitive recording medium | NIPPON PAPER INDUSTRIES CO., LTD. | 2024-02-27 | — | — | US | disclosed |
| US-4849531-A | Process for the preparation of 2,3-epoxyamides | BAYER AKTIENGESELLSCHAFT (DE) | 1989-07-18 | — | — | US | disclosed |
| EP-0292808-A2 | Substituted vinyl cephalosporins, process for their preparation and their use as medicines | BAYER AG (DE) | 1988-11-30 | — | — | EP | disclosed |
| EP-0284954-A2 | Cephalosporinderivatives, process for their preparation and their use in pharmaceutical products | BAYER AG (DE) | 1988-10-05 | — | — | EP | disclosed |
| EP-0244717-A2 | Process for the preparation of 2,3-epoxyamides | BAYER AG (DE) | 1987-11-11 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100029957-A1 | Semi-Synthetic Process for the Preparation of Taxane Derivatives | WEE1, WEE2, NOTUM | ALDH1A1 3681/4885CYP2A6 435/4885CA12 3542/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.